✦ LIBER ✦

Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea

✍ Scribed by Dr Jacob I. Sage; Margery H. Mark; Denise M. McHale; Patricia K. Sonsalla; Dawn Vitagliano

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 552 KB
Volume: 29
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410290609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacological therapeutic manageme

The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson’s disease

✍ Olivier Rascol 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 45 KB

Alterations in opioid receptor binding i

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

✍ Dr. P. Piccini; R. A. Weeks; D. J. Brooks 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 729 KB

Exercise improves efficacy of levodopa i

Exercise improves efficacy of levodopa in patients with Parkinson's disease

✍ Siegfried Muhlack; Jacub Welnic; Dirk Woitalla; Thomas Müller 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract The objective was to investigate the impact of exercise on absorption and efficacy of levodopa (LD) in patients with Parkinson‘s disease (PD). A soluble, immediate release LD formulation was given followed by exercise near the aerobic limit on one day to PD patients, who underwent the s

The influence of levodopa-induced dyskin

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson’s disease

✍ Sarah Lemieux; Mehrdad Ghassemi; Mandar Jog; Roderick Edwards; Christian Duval 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 459 KB

Effects of levodopa and COMT inhibitors

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

✍ Paolo Lamberti; Stefano Zoccolella; Giovanni Iliceto; Elio Armenise; Angela Frad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). T

Levodopa-induced regional cerebral blood

Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease

✍ J. L. Montastruc; Dr. P. Celsis; A. Agniel; J. F. Demonet; B. Doyon; M. Puel; J. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

Single photon emission computed tomography was used to measure regional cerebral blood flow in six normal subjects and 12 patients with Parkinson's disease, before and after acute oral administration of levodopa. The drug induced a significant increase in cerebral blood flow both in controls and pat